Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Inhalable Drugs Industry Trends and Competitive Landscape 2023-2027" report has been added to ResearchAndMarkets.com's offering.
The global inhalable drugs market is on a trajectory of substantial growth, expected to increase from $31.20 billion in 2022 to $33.29 billion in 2023, marking a compound annual growth rate (CAGR) of 6.7%. The market is predicted to reach $42.76 billion in 2027, growing at a CAGR of 6.5%.
The rising prevalence of respiratory diseases is expected to be a significant driver for the inhalable drug market. Inhalable drugs play a pivotal role in treating various respiratory disorders by delivering medication directly to the lungs.
For example, in June 2023, data from the Australian Institute of Health and Welfare revealed that Australia witnessed around 6,551 deaths due to respiratory chronic conditions in 2021, accounting for 27.1% of all deaths. Chronic obstructive pulmonary disease (COPD) contributed to 2.6% of underlying-cause respiratory deaths. The increasing prevalence of respiratory diseases is expected to drive future growth in the inhalable drug market.
Innovation Taking Center Stage in the Inhalable Drug Market
Innovation is a key trend in the inhalable drug market as major companies focus on advancing inhalable drugs to maintain their market position. For instance, in July 2022, DMV-Fonterra Excipients GmbH & Co. KG, a German pharmaceutical company, expanded its dry powder inhalation (DPI) portfolio with the introduction of Lactohale 400. This innovative grade can be customized to meet the specific needs of pharmaceutical companies, ensuring positive patient outcomes. Lactohale 400, a crushed, dry lactose type, is suitable for DPI applications requiring high flow and cohesiveness. Its anhydrous nature sets it apart from commonly used lactose carriers, offering different aerosolization performance despite having the same particle size as lactose monohydrate.
Regional Insights: North America Leads, Asia-Pacific Shows Promise
In 2022, North America stood as the largest region in the inhalable drugs market. However, Asia-Pacific is expected to be the fastest-growing region in the forecast period. The market report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa. It includes countries like Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, the USA, Italy, Spain, and Canada.
Prominent Players in the Inhalable Drugs Market
The inhalable drugs market features several major players, including:
- Pfizer Inc.
- Merck & Co. Inc.
- Novartis AG
- Sanofi SA
- AstraZeneca plc
- GlaxoSmithKline Plc
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Koninklijke Philips N.V.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Catalent Inc.
- Sumitomo Pharma Co. Ltd.
- Intertek Group plc
- AptarGroup Inc.
- Cipla Inc.
- Glenmark Pharmaceuticals Inc.
- Piramal Pharma Ltd.
- Zambon S.p.A.
- Sunovion Pharmaceuticals Inc.
- Nelson Laboratories LLC
- Vectura Group Limited
- Abiogen Pharma
- Quotient Sciences
- AeroGen Pharma
- CareFusion Corporation
- Alaxia S.A.S.
- Pharmaxis Ltd.
- Avalyn Pharma Inc.
- TFF Pharmaceuticals Inc.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2023-2027 |
| Estimated Market Value (USD) in 2023 | $33.29 Billion |
| Forecasted Market Value (USD) by 2027 | $42.76 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
Key Topics Covered
1. Executive Summary
2. Inhalable Drugs Market Characteristics
3. Inhalable Drugs Market Trends and Strategies
4. Inhalable Drugs Market - Macro Economic Scenario
4.1. Impact of High Inflation on Online Therapy Services Market
4.2. Ukraine-Russia War Impact on Online Therapy Services Market
4.3. COVID-19 Impact on Online Therapy Services Market
5.1. Global Inhalable Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Inhalable Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Inhalable Drugs Market Drivers and Restraints
5.3.1. Drivers of the Market
5.3.2. Restraints of the Market
6. Inhalable Drugs Market Segmentation
6.1. Global Inhalable Drugs Market, Segmentation by Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Aerosol
- Dry Powder Formulation
- Spray
6.2. Global Inhalable Drugs Market, Segmentation by Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospital Pharmacy
- Pharmacy Stores
- Other Distribution Channels
6.3. Global Inhalable Drugs Market, Segmentation by Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Respiratory Diseases
- Non-Respiratory Disease
6.4. Global Inhalable Drugs Market, Segmentation by End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Adults
- Pediatric
- Geriatric
7. Inhalable Drugs Market Regional and Country Analysis
7.1. Global Inhalable Drugs Market, Split by Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Inhalable Drugs Market, Split by Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/nidtsx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
